ADAMTS13-containing compositions having thrombolytic activity
US10233436B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jan 22, 2013 |
| Grant date | Mar 19, 2019 |
| Priority date | — |
| Expiry date | Oct 6, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a pharmaceutical composition having thrombolytic activity comprising ADAMTS13, and to methods for treating or preventing a disorder associated with the formation and/or the presence of one or more thrombus and to methods of disintegrating one or more thrombus in a patient in need thereof. Furthermore, the invention relates to the use of a pharmaceutically effective amount of ADAMTS13 for the preparation of a pharmaceutical composition for treating or preventing a disorder associated with the formation or the presence of one or more thrombus and for disintegrating one or more thrombus in a patient in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.